Shares of Elbit Systems plunged as much as 9.8% on Tuesday despite the Israeli defense contractor delivering one of its strongest quarters on record, a textbook "sell the news" reaction that raises hard questions about how much growth the stock had already priced in after an 80% rally over the past year.
• A Blowout Quarter Wasn't Enough to Satisfy a Lofty Price Tag
Elbit posted non-GAAP earnings of $4.14 per share on revenue of $2.3 billion, smashing Wall Street estimates of $3.24 and $2.22 billion, respectively.
Revenue rose 15.9% year-over-year while backlog reached a record $32 billion. Yet GAAP EPS of $3.61 represented a sequential step down from Q1's $3.87, a detail that may have disappointed investors who had priced in continued sequential acceleration.
The stock had been trading at a steep premium to both its own historical price-to-earnings ratio and the broader aerospace and defense peer group.
• Aerospace Weakness and Rising Costs Spooked Investors
Shares fell after results showed a decline in aerospace revenue while spending on research and development climbed. For shareholders, higher R&D spend pressures near-term profit margins even if it fuels longer-term competitiveness — a trade-off the market was unwilling to reward at current valuations.
• A Record Backlog Doesn't Automatically Mean Record Profits
About 73% of the $32 billion backlog comes from orders outside Israel, and approximately 42% is scheduled for delivery during the remainder of 2026 and 2027. That's impressive visibility, but converting orders into cash depends on capacity. Management said it is raising capital expenditures to approximately $300 million from $220 million to add production capacity — a 36% jump that will weigh on free cash flow in coming quarters. Operating cash flow was $237 million (up from $120 million), and free cash flow hit $150 million versus $71 million a year earlier , but sustaining that conversion rate while ramping capex is the key execution test ahead.
• Geopolitics Add a Layer of Uncertainty
Operations continue to be affected by conflicts in the Middle East, including renewed hostilities between the U.S. and Iran following the collapse of a memorandum of understanding. While conflict historically drives defense orders, it also introduces supply-chain disruption and political risk that investors must weigh against backlog growth.
Bottom line: Elbit's fundamentals are the best they've been — but after nearly doubling in a year, the stock needed a perfect story, not just a great one. The next quarters will hinge on whether the company can turn a mountain of orders into actual cash without margin erosion.